Cartesian Therapeutics Inc (RNAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 118,641 | 125,139 | 143,384 | 160,324 | 180,434 |
| Receivables | 261 | 1,115 | 722 | 354 | 1,765 |
| TOTAL | $122,039 | $129,276 | $147,260 | $163,395 | $185,120 |
| Non-Current Assets | |||||
| PPE Net | 11,637 | 12,185 | 12,394 | 12,285 | 10,174 |
| Investments And Advances | 0 | 0 | 2,000 | 2,000 | 2,000 |
| Intangibles | 48,163 | 48,163 | 48,163 | 48,163 | 48,163 |
| Other Non-Current Assets | 106,552 | 106,787 | 162,858 | 163,050 | 163,673 |
| TOTAL | $166,352 | $167,135 | $225,415 | $225,498 | $224,010 |
| Total Assets | $288,391 | $296,411 | $372,675 | $388,893 | $409,130 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,598 | 1,288 | 2,225 | 454 | 2,097 |
| Accrued Expenses | 10,161 | 9,498 | 7,702 | 8,012 | 9,197 |
| TOTAL | $15,945 | $14,937 | $13,803 | $12,256 | $14,998 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 413,616 | 400,766 | 378,575 | 363,023 | 399,780 |
| TOTAL | $420,564 | $407,714 | $394,716 | $379,164 | $415,921 |
| Total Liabilities | $436,509 | $422,651 | $408,519 | $391,420 | $430,919 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,382 | 26,509 | 26,004 | 26,002 | 25,954 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -861,555 | -822,373 | -729,797 | -693,895 | -709,781 |
| Other shareholders' equity | -4,583 | -4,576 | -4,587 | -4,577 | -4,589 |
| TOTAL | $-148,118 | $-126,240 | $-35,844 | $-2,527 | $-21,789 |
| Total Liabilities And Equity | $288,391 | $296,411 | $372,675 | $388,893 | $409,130 |